Bookmarks
Manage BookmarksYou have no bookmarks!
Click on the bookmark icon on your favorite pages for easy access, or click on the "Manage Bookmarks" above.
Subject Expert

Jackson Tate
Research Director
Trending Filters
Preferences
Does this page look different?
Get a summary of what's new.
Get a tour.
Overall Score Filtered view: ##.# Segment Average ##.#
Single Physician
The product does not have 15 surveys from facilities with 2-10 physicians, but has at least 15 when including surveys from single physician facilities.
Component
Solution that typically includes most but not all components that comprise a complete system or that serves only a subset of the market.
Limited market share
This solution does not have a sufficient number of live customers to qualify for a Best in KLAS ranking.
Not primary
Solution is not the vendor’s lead product in the category but may still be purchased.
Regional
Solution for which the majority of data comes from organizations located in the same, small geographical area.
Superseded
Legacy solutions or other solutions that are not generally marketed or whose marketing is superseded by another solution in the same category.
Emerging technology
Solution is new/emerging and has yet to meet standard data level qualifications. Designation will be removed once solution meets the qualifications.
Market Energy
This is an indication of the relative considerations of Market Energy within the shown products from the
Decision Insights KLAS Data
Market Energy Levels:
Low Market Energy | |
Medium Market Energy | |
High Market Energy | |
Not Enough Data |
Org Sample Size
- n = total survey sample size
- u = # of unique organizations surveyed
If you don't have a login, getting started is easy.
Score Breakdown (1 Year) Filtered view:
Promote Product
Want to directly encourage your clients to share candid feedback?
To help ensure KLAS ratings are always accurate, honest, and impartial, all vendors must adhere to the guidelines below:
- Coordinate encouragement efforts with KLAS. Please notify KLAS before inviting client contacts to participate. Aligning with KLAS’ efforts optimizes the response.
- ALL customers must simultaneously be invited to participate, not a selected sub-group (unless approved by KLAS). Your KLAS representative MUST receive a copy of the invitation sent to client contacts.
- You may utilize the sample email template to encourage customers to respond to KLAS’ invitation.
- Do NOT provide any incentive to customer participants for evaluating a product through KLAS (cash, gift cards, random prize drawings, etc)
Aside from the KLAS-coordinated encouragement outlined above, all online evaluations received as a result of vendor encouragement will be quarantined until KLAS validation and bias checks are satisfied. Evaluations deemed to be cherry-picked or biased are discarded.
Latest Comments See all (54) comments Filtered view: ##.#% ##.#% ##.#% Download as Excel
Manager
Product
The beautiful thing about something like Sentri7 Drug Diversion is the...
Manager
Operations
Wolters Kluwer has been very robust just technologically. We can tell...
Manager
Product
Sentri7 Drug Diversion has a very mature user interface. It is very...
Manager
Product, Value
With Sentri7 Drug Diversion we have seen an improvement in the time it...
Director
Loyalty, Product
The vendor is working on Sentri7 Drug Diversion’s ease of use with...
Director
Culture, Loyalty
We have a few years left in our contract with Wolters Kluwer. We do...
Director
Product, Value
Since we have been using Sentri7 Drug Diversion, we have caught a few...
Director
Operations, Product
Getting a higher score on ROI goes back to improving usability and...
Director
Operations
During the implementation phase for Sentri7 Drug Diversion, there was...
Director
Operations
During the initial sale, Invistics said that Sentri7 Drug Diversion...